PI3Kδ-IN-2

CAS No. 1702816-75-8

PI3Kδ-IN-2( —— )

Catalog No. M20551 CAS No. 1702816-75-8

PI3Kδ-IN-2 is a potent and selective inhibitor of PI3Kδ .

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 80 In Stock
2MG 38 In Stock
5MG 61 In Stock
10MG 92 In Stock
25MG 202 In Stock
50MG 305 In Stock
100MG 477 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    PI3Kδ-IN-2
  • Note
    Research use only, not for human use.
  • Brief Description
    PI3Kδ-IN-2 is a potent and selective inhibitor of PI3Kδ .
  • Description
    PI3Kδ-IN-2 is a potent and selective inhibitor of PI3Kδ.(In Vitro):Linperlisib (YY-20394) is under the study for the recurrent and/or refractory follicular lymphoma.
  • In Vitro
    Linperlisib (YY-20394) is under the study for the recurrent and/or refractory follicular lymphoma.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    PI3K/Akt/mTOR signaling
  • Target
    PI3K
  • Recptor
    PI3Kδ
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1702816-75-8
  • Formula Weight
    588.69
  • Molecular Formula
    C28H37FN6O5S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:25 mg/mL (42.47 mM)
  • SMILES
    COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2c(CN3CCC(CC3)C(C)(C)O)cc(F)cc12)N1CCOCC1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • GNE-317

    GNE-317 (GNE317) is a potent, brain penepenetrant, dual PI3K/mTOR inhibitor having physicochemical properties predictive of low efflux by P-gp and BCRP.

  • mTOR inhibitor 9d

    mTOR inhibitor 9d is a dual inhibitor of the protein kinases mTOR and PI3K with an mTOR IC50 value of 0.31 nm, and can be used for the treatment of leukemia, skin cancer, breast cancer, lung cancer and colon cancer.

  • Voxtalisib

    A potent, highly selective ATP-competitive inhibitor of class I PI3Ks.